Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein
- PMID: 8496787
Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein
Abstract
The transactivator proteins of HIV-1 and HIV-2, Tat-1 and Tat-2, are highly homologous in the center of each molecule but are divergent in the amino and carboxy termini. The structure of Tat-1 has been extensively characterized by mutagenesis studies, whereas little is as yet known specifically about the structure of Tat-2. To characterize the Tat-2 protein, we performed a mutational analysis of the amino and carboxy termini of the fully functional first exon (99 residues) of the Tat-2 protein. We found that deletion of residues 8 through 33 in the amino terminus drastically reduced transactivation activity, whereas deletion of residues 8 through 47 largely abolished transactivation activity. We also analyzed chimeric proteins in which the amino termini of the Tat-1 and Tat-2 proteins were exchanged precisely at the first cysteine in the cysteine-rich regions. Both chimeric proteins possessed very low levels of transactivation activity, indicating that the amino termini of Tat-1 and Tat-2 are not interchangeable. Truncation mutants in the carboxy terminus were analyzed and amino acid 90 at the end of the basic domain was found to be at or near the limit of carboxy residues that can be deleted without abolishing Tat-2 function. A Tat-2 mutant truncated after residue 84 within the basic domain was found to be a transdominant mutant able to inhibit wild-type Tat-1 and wild-type Tat-2 activities. Additionally, the results of immunoprecipitations suggested that deletions in the Tat-2 amino terminus can reduce protein stability.
Similar articles
-
Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.J Acquir Immune Defic Syndr (1988). 1994 Jul;7(7):655-64. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8207644
-
Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.J Virol. 1990 Dec;64(12):6018-26. doi: 10.1128/JVI.64.12.6018-6026.1990. J Virol. 1990. PMID: 2243385 Free PMC article.
-
Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.J Virol. 1996 Nov;70(11):8055-63. doi: 10.1128/JVI.70.11.8055-8063.1996. J Virol. 1996. PMID: 8892930 Free PMC article.
-
Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.Virology. 1993 Jun;194(2):530-6. doi: 10.1006/viro.1993.1291. Virology. 1993. PMID: 8389074
-
The tat gene and protein of the human immunodeficiency virus type 1.New Microbiol. 1995 Jan;18(1):87-110. New Microbiol. 1995. PMID: 7760763 Review. No abstract available.
Cited by
-
Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.Int J Mol Sci. 2020 Aug 17;21(16):5907. doi: 10.3390/ijms21165907. Int J Mol Sci. 2020. PMID: 32824587 Free PMC article.
-
Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.Nucleic Acids Res. 1994 Oct 25;22(21):4405-13. doi: 10.1093/nar/22.21.4405. Nucleic Acids Res. 1994. PMID: 7971271 Free PMC article.
-
Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.J Virol. 1995 Mar;69(3):1612-20. doi: 10.1128/JVI.69.3.1612-1620.1995. J Virol. 1995. PMID: 7853496 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources